BKD:NYE-Brookdale Senior Living Inc (USD)

COMMON STOCK | Medical Care Facilities | NYE

Last Closing Price

USD 5.20

Change

0.00 (0.00)%

Market Cap

USD 0.96B

Volume

2.62M

Avg Analyst Target

USD 8.00 (+53.85%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Brookdale Senior Living Inc (BKD) Stock Analysis:
Based on the Brookdale Senior Living Inc stock forecasts from 1 analysts, the average analyst target price for Brookdale Senior Living Inc is USD 8.00 over the next 12 months. Brookdale Senior Living Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Brookdale Senior Living Inc is Slightly Bearish, which is based on 4 positive signals and 9 negative signals. At the last closing, Brookdale Senior Living Inc’s stock price was USD 5.20. Brookdale Senior Living Inc’s stock price has changed by -0.21% over the past week, +0.03% over the past month and +5.91% over the last year.

About

Brookdale Senior Living Inc. owns and operates senior living communities in the United States. It operates through five segments: Independent Living, Assisted Living and Memory Care, Continuing Care Retirement Communities (CCRCs), Health Care Services, and Management Services. Th ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-23 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HCA HCA Healthcare Inc

N/A

USD74.00B 12.18 8.20
FMS Fresenius Medical Care AG & Co..

N/A

USD19.17B 18.41 8.41
DVA DaVita Inc

N/A

USD11.15B 12.77 8.80
UHS Universal Health Services Inc

N/A

USD10.32B 10.33 7.08
THC Tenet Healthcare Corporation

N/A

USD8.14B 7.68 5.16
CHE Chemed Corporation

N/A

USD7.24B 24.69 17.40
AGL agilon health inc

N/A

USD6.42B N/A N/A
EHC Encompass Health Corporation

N/A

USD6.22B 15.39 8.94
OSH Oak Street Health Inc

N/A

USD4.61B N/A N/A
AMN AMN Healthcare Services Inc

N/A

USD4.42B 20.33 13.68

ETFs Containing BKD

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.78% 95% A 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.78% 95% A 82% B-
Trailing 12 Months  
Capital Gain 5.91% 79% C+ 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.91% 79% C+ 51% F
Trailing 5 Years  
Capital Gain -66.60% 7% F 6% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -66.60% 7% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain 1.58% 32% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.58% 32% F 18% F
Risk Return Profile  
Volatility (Standard Deviation) 68.50% 21% F 11% F
Risk Adjusted Return 2.30% 32% F 14% F
Market Capitalization 0.96B 27% F 49% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 800.22 6% F 1% F
Price/Book Ratio 1.31 83% B 63% D
Price / Cash Flow Ratio 4.69 50% F 64% D
EV/EBITDA 11.52 35% F 52% F
Management Effectiveness  
Return on Equity -7.54% 35% F 17% F
Return on Invested Capital 0.04% 32% F 32% F
Return on Assets -1.37% 19% F 14% F
Debt to Equity Ratio 480.63% 35% F 6% F
Technical Ratios  
Short Ratio 3.10 55% F 30% F
Short Percent 5.32% 32% F 38% F
Beta 1.76 17% F 15% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector